Post-Cardiac-Arrest Target Temperature With Bradycardia and Recurrent Seizures
A 58-year-old man is comatose 6 hours after an out-of-hospital cardiac arrest (witnessed, bystander CPR, initial rhythm VF, ROSC at 22 minutes). He is intubated and sedated with propofol and fentanyl, on norepinephrine 0.08 mcg/kg/min. Core temp 36.8 C. He has had two electrographic seizures on continuous EEG in the last hour, treated with levetiracetam load. HR 48, BP 92/54, SpO2 96% on FiO2 0.40. Lactate 2.1. He has no corneal or gag reflex; pupils 3 mm and reactive. CT head is unremarkable. The ICU is at full capacity and the cooling device is shared with another patient for the next 4 hours.
1. Should this patient be cooled to 33 C, 36 C, or not at all? Justify using the evidence and this patient's specific physiology.
Read the worked answer
Targeted temperature management is indicated: he is comatose post-ROSC with a shockable initial rhythm and no contraindication. The pivotal trials (TTM 2013; HYPERION 2019) show no mortality difference between 33 C and 36 C in the overall population, and 33 C is not required. However, the choice here is constrained by physiology: he is already bradycardic (HR 48) and borderline hypotensive on norepinephrine. Cooling to 33 C predictably worsens bradycardia and can increase vasopressor requirement via cold-induced diuresis and increased SVR/afterload mismatch. A reasonable target is 36 C (or 32-36 C per institutional protocol), avoiding fever strictly. The key exam point is that 33 C is a permitted but not mandatory option, and the decision should be individualized: a patient with bradycardia and pressor dependence is a strong argument for the higher end of the range. Document the target, avoid fever, and reassess hemodynamics.
2. The cooling device is unavailable for 4 hours. What do you do in the interim, and what is the harm of waiting?
Read the worked answer
Do not simply wait. Initiate active fever prevention immediately with available means: surface cooling (ice packs to groin/axillae, cooled IV fluids cautiously given his hemodynamics), antipyretics, and set the bed/room to a cool environment while maintaining the 36 C target. The harm of delay is not that he "misses the window" for a mortality benefit (which is unproven at 33 C vs 36 C), but that hyperthermia in the first 72 hours is independently associated with worse neurologic outcome. The real risk is uncontrolled temperature drift upward. So the priority is preventing fever now, not achieving a specific device-based target. Also note: if the plan is 36 C, the device is less critical than if the plan were 33 C - another reason the 36 C target is operationally sensible here. Reassess device availability and escalate to charge nurse/bed management.
3. He develops recurrent electrographic seizures despite levetiracetam. What is your next step and how does temperature interact with seizure management?
Read the worked answer
Escalate to a second agent (e.g., fosphenytoin or valproate, or lacosamide) and, for refractory electrographic status, consider a midazolam or propofol infusion titrated to EEG burst suppression with continuous EEG monitoring. Two interactions matter: (1) hypothermia (33 C) can suppress seizure activity on EEG and mask ongoing status, so if you cool, you must maintain EEG monitoring; (2) many antiseizure drugs and sedatives are affected by temperature and by the hemodynamic state - propofol at high dose plus bradycardia plus norepinephrine is a precarious combination, so consider midazolam with careful titration. His bradycardia (HR 48) argues against adding high-dose propofol and against deep hypothermia. The judgment call: treat the seizures aggressively because ongoing electrographic status worsens outcome, but choose agents that do not compound his bradycardia and hypotension.